Immunité et Cancer
- World rank, all time
- #7,278 of 42,892
- Rank in France
- #454 of 2,321
- Research works
- 233 ▲ 42% vs 2013–17
- Citations
- 12k 53.5 per fractional work
- Top-10% rate
- 26.6% record average 16.5%
- Open access
- 64% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 19.5×. Every wedge is a field page.
- Immunology and Microbiology 19.5×
- Biochemistry, Genetics and Molecular Biology 3.7×
- Medicine 2.4×
- Chemistry 0.7×
- Pharmacology, Toxicology and Pharmaceutics 0.7×
- Nursing 0.7×
- Veterinary 0.6×
- Decision Sciences 0.6×
- Neuroscience 0.4×
- Physics and Astronomy 0.3×
- Health Professions 0.3×
- Engineering 0.3×
- Economics, Econometrics and Finance 0.2×
- Computer Science 0.2×
- Environmental Science 0.2×
- Mathematics 0.2×
- Agricultural and Biological Sciences 0.1×
- Psychology 0.1×
- Materials Science 0.1×
- Energy 0.1×
- Social Sciences 0.0×
Which keywords describe research at Immunité et Cancer?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Cancer Immunotherapy, Tumor Microenvironment, Immunity, Immunotherapy, Inflammation, Natural Killer Cells and NK Cell Recognition.
- Targeted Therapy
- Radiotherapy
- Angiogenesis
- Cancer Therapy
- Metastasis
- Clinical Practice Guidelines
- Biomarkers
- CD4+CD25+
- Tumor Antigen
- Immune Response
- Dendritic Cells
- Autoimmunity
- CAR T Cells
- Tumor Regression
- Innate Immunity
- PD-1 and PD-L1
- Natural Killer Cells
- Immunotherapy
- Tumor Microenvironment
- Inflammation
- Cancer
- Cancer Immunotherapy
- Immunity
- NK Cell Recognition
- Immune Checkpoint Blockade
- Lymphoma
- Chemotherapy
- Antigen Presentation
- Chimeric Antigen Receptor
- Metabolism
- Gene Expression
- TGF-ß
- Vaccine Adjuvants
- Foxp3
- Activation
- Macrophage
- Polarization
- Prognostic Factors
- Breast Cancer
- Survival Analysis
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer6▲ 7.4×22 topics
- Inflammation5▲ 4.4×33 topics
- Cancer Immunotherapy5▲ 53×3 topics
- Tumor Microenvironment4▲ 17×8 topics
- Immunity4▲ 18×8 topics
- Immunotherapy4▲ 10×16 topics
- NK Cell Recognition3▲ 84×1 topic
- Natural Killer Cells3▲ 84×1 topic
- Immune Checkpoint Blockade3▲ 44×1 topic
- PD-1 and PD-L13▲ 44×1 topic
- Lymphoma3▲ 28×2 topics
- Innate Immunity2▲ 14×6 topics
- Chemotherapy2▲ 6.0×18 topics
- Tumor Regression2▲ 38×2 topics
- Antigen Presentation2▲ 44×2 topics
- CAR T Cells2▲ 52×1 topic
- Chimeric Antigen Receptor2▲ 52×1 topic
- Autoimmunity2▲ 26×4 topics
- Metabolism2▲ 7.2×8 topics
- Dendritic Cells2▲ 39×2 topics
- Gene Expression2▲ 5.8×9 topics
- Immune Response2▲ 6.1×16 topics
- TGF-ß2▲ 22×4 topics
- Tumor Antigen2▲ 55×1 topic
- Vaccine Adjuvants2▲ 55×1 topic
- CD4+CD25+2▲ 90×1 topic
- Foxp32▲ 90×1 topic
- Biomarkers2▲ 4.1×9 topics
- Activation1▲ 42×1 topic
- Clinical Practice Guidelines1▲ 4.4×8 topics
- Macrophage1▲ 35×2 topics
- Metastasis1▲ 7.0×7 topics
- Polarization1▲ 16×1 topic
- Cancer Therapy1▲ 4.1×14 topics
- Prognostic Factors1▲ 5.4×9 topics
- Angiogenesis1▲ 6.2×10 topics
- Breast Cancer1▲ 8.6×7 topics
- Radiotherapy1▲ 5.5×9 topics
- Survival Analysis1▲ 6.9×5 topics
- Targeted Therapy1▲ 8.6×5 topics
Which research topics does Immunité et Cancer publish most on?
By volume in 2022–2025: Immune Cell Function and Interaction, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research and Immunotherapy and Immune Responses.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Immune Cell Function and Interaction Immunology 3 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 3 works
- 3 CAR-T cell therapy research Oncology 2 works
- 4 Immunotherapy and Immune Responses Immunology 2 works
- 5 T-cell and B-cell Immunology Immunology 2 works
- 6 Immune cells in cancer Immunology 1 works
- 7 Cytomegalovirus and herpesvirus research Epidemiology 1 works
- 8 RNA modifications and cancer Molecular Biology 1 works
- 9 DNA Repair Mechanisms Molecular Biology 1 works
- 10 CRISPR and Genetic Engineering Molecular Biology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Immunité et Cancer's research output changed?
Output in 2018–2022 was 42% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Paris
- Centre National de la Recherche Scientifique
- Inserm
- Sorbonne Université
- Université Paris Cité
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives
- Université Paris 1 Panthéon-Sorbonne
- Institut Pasteur
- Assistance Publique – Hôpitaux de Paris
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.